Nanoparticles and antigen-specific T-cell therapeutics: a comprehensive study on uptake and release

Area of Science:

• Immunology
• Nanotechnology
• Biomedical Engineering

Background:

• T lymphocytes are crucial cellular therapeutics for various diseases, including cancer.
• Investigating nanoparticle interaction with nonphagocytic T cells is vital for advancing nanomedicine.

Purpose of the Study:

• To investigate the uptake and retention of nanoparticles (NPs) by T lymphocytes.
• To assess the impact of NPs on T-cell effector functions.

Main Methods:

• Utilized flow cytometry, confocal laser scanning microscopy, and transmission electron microscopy to analyze NP uptake, release, and toxicity.
• Assessed T-cell effector functions using IFN-γ-ELISPOT and (51)Chromium-release assays.

Main Results:

• Amino-functionalized NPs were efficiently ingested by antigen-specific T cells.
• NPs were stored in membrane-surrounded vesicles and largely released extracellularly within 24 hours.
• NP uptake did not adversely affect T-cell effector functions.

Conclusions:

• Amino-functionalized polymeric NPs demonstrate efficient uptake by human T cells.
• These NPs show promise as nanocarriers for in vivo manipulation of antigen-specific T cells.
• The findings support the development of novel nanocarrier systems for T-cell-based therapies.